<p>Guwahati: Indian Institute of Technology (IIT), Guwahati has successfully transferred a 'pioneering' vaccine technology to a manufacturing company specialising in high-quality vaccines for combating swine fever virus in pigs and wild boars, a release said on Tuesday.</p>.<p>This vaccine marks the first recombinant virus-based solution for classical swine fever developed in India, offering a swift and cost-effective method for pig vaccination.</p>.<p>The technology has been successfully transferred to BioMed Pvt Ltd for commercial production of the innovative vaccine, the release said.</p>.Fire at Noida Authority's dumping yard, flames continue for over 18 hours.<p>The vaccine for pigs harnesses a reverse genetic platform pioneered and refined at IIT Guwahati.</p>.<p>Swine fever, a highly contagious disease among pigs, poses a severe threat with a very high mortality rate, although it does not affect humans.</p>.<p>In India, instances of this disease have been frequently observed in North Eastern states as well as in Bihar, Kerala, Punjab, Haryana, and Gujarat, among others.</p>.<p>The vaccine work was started in 2018-19 through collaborative efforts between researchers from the Department of Biosciences and Bioengineering at IIT Guwahati, and Assam Agricultural University in Guwahati.</p>.<p>Their research findings have been published in two papers, and featured in Process Biochemistry and Archives of Virology journals.</p>.<p>This vaccine is being created and produced for the first time in India.</p>.<p>Transferring the vaccine technology to one of the leaders in the veterinary vaccine sector marks a remarkable achievement, the release said.</p>.<p>At present, the vaccine is under the process of filing test and analysis licence, it added.</p>.<p>Reverse genetics stands as a potent method and tool for the development of vaccines targeting both animal and human diseases. The technology has been widely used to develop vaccines against influenza.</p>.<p>The researchers have utilised the Newcastle disease virus (NDV), traditionally studied for its pathogenicity in chickens, as a carrier for the essential proteins of the classical swine fever virus.</p>.<p>This innovative method facilitates the development of immunity in the body and is characterised by its speed and cost-effectiveness, the release added.</p>
<p>Guwahati: Indian Institute of Technology (IIT), Guwahati has successfully transferred a 'pioneering' vaccine technology to a manufacturing company specialising in high-quality vaccines for combating swine fever virus in pigs and wild boars, a release said on Tuesday.</p>.<p>This vaccine marks the first recombinant virus-based solution for classical swine fever developed in India, offering a swift and cost-effective method for pig vaccination.</p>.<p>The technology has been successfully transferred to BioMed Pvt Ltd for commercial production of the innovative vaccine, the release said.</p>.Fire at Noida Authority's dumping yard, flames continue for over 18 hours.<p>The vaccine for pigs harnesses a reverse genetic platform pioneered and refined at IIT Guwahati.</p>.<p>Swine fever, a highly contagious disease among pigs, poses a severe threat with a very high mortality rate, although it does not affect humans.</p>.<p>In India, instances of this disease have been frequently observed in North Eastern states as well as in Bihar, Kerala, Punjab, Haryana, and Gujarat, among others.</p>.<p>The vaccine work was started in 2018-19 through collaborative efforts between researchers from the Department of Biosciences and Bioengineering at IIT Guwahati, and Assam Agricultural University in Guwahati.</p>.<p>Their research findings have been published in two papers, and featured in Process Biochemistry and Archives of Virology journals.</p>.<p>This vaccine is being created and produced for the first time in India.</p>.<p>Transferring the vaccine technology to one of the leaders in the veterinary vaccine sector marks a remarkable achievement, the release said.</p>.<p>At present, the vaccine is under the process of filing test and analysis licence, it added.</p>.<p>Reverse genetics stands as a potent method and tool for the development of vaccines targeting both animal and human diseases. The technology has been widely used to develop vaccines against influenza.</p>.<p>The researchers have utilised the Newcastle disease virus (NDV), traditionally studied for its pathogenicity in chickens, as a carrier for the essential proteins of the classical swine fever virus.</p>.<p>This innovative method facilitates the development of immunity in the body and is characterised by its speed and cost-effectiveness, the release added.</p>